Videos of Dr Alexander Lyon

Prevalence of CVD and Assessment of CV Risk in Patients with Prostate Cancer

Description:

Dr. Alexander Lyon presented “Prevalence of CVD and Assessment of CV Risk in Patients with Prostate Cancer” at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), which was held in Lisbon, Portugal between October 14th and 16th 2016. STOP-6 was accredited for CME by the European Accreditation Council for CME (UEMS-EACCME). The meeting was organized by Bioscript and the Scientific Committee, composed of Professors Laurence Klotz (Chair), Noel Clarke, Karim Fizazi and Bertrand Tombal. Funding to support this educational activity was provided by FERRING Pharmaceuticals. FERRING did not influence meeting content and the views expressed during the meeting represent only those of the faculty.